文献速递炎症性肠病胃肠动力与功能性疾病

药物使用与显微镜性结肠炎:多中心回顾性队列研究

Medication use and microscopic colitis: a multicentre retrospective cohort study.
PubMed 文献 · Aliment Pharmacol Ther · 2021-04-14

该多中心回顾性队列研究在哥伦比亚大学医学中心和梅奥诊所10年间接受结肠镜检查的患者中,比较活检证实的显微镜性结肠炎(MC)患者与因腹泻行结肠镜但活检阴性的对照,按年龄、性别和日历期匹配。调整吸烟后,NSAID使用与MC正相关(OR 1.63;95%CI 1.12-2.38),PPI(OR 0.64;95%CI 0.47-0.87)、H2受体阻滞剂(OR 0.46;95%CI 0.24-0.88)和口服降糖药(OR 0.47;95%CI 0.27-0.81)与MC呈反向关联。作者指出腹泻对照的选择可能促成反向关联,建议未来药物诱导MC研究应纳入腹泻对照。

要点

  • NSAID使用与显微镜性结肠炎风险升高相关(OR 1.63;95%CI 1.12-2.38)。
  • PPI、H2受体阻滞剂和口服降糖药与MC呈反向关联,可能受腹泻对照选择影响。
  • 未来药物诱导MC研究应设腹泻对照,而非仅用健康对照。

核心结论

  • NSAID使用与显微镜性结肠炎相关,而PPI、H2受体阻滞剂和口服降糖药与MC呈反向关联。
  • 使用腹泻对照而非健康对照可能促成上述反向关联。

研究设计与样本

  • 多中心回顾性队列研究,纳入哥伦比亚大学医学中心和梅奥诊所10年间接受结肠镜检查的患者。
  • 病例为活检证实的MC患者,对照为因腹泻行结肠镜且活检排除MC的患者。
  • 病例按年龄、性别和日历期与最多两名对照匹配。
  • 共纳入344例MC患者和668例对照。
  • 采用条件logistic回归,并分别进行未调整和吸烟调整分析。

主要发现

  • 调整吸烟后,MC与PPI使用呈反向关联(OR 0.64;95%CI 0.47-0.87)。
  • 调整吸烟后,MC与H2受体阻滞剂使用呈反向关联(OR 0.46;95%CI 0.24-0.88)。
  • 调整吸烟后,MC与口服降糖药使用呈反向关联(OR 0.47;95%CI 0.27-0.81)。
  • 调整吸烟后,NSAID使用与MC呈正关联(OR 1.63;95%CI 1.12-2.38)。

关键数值与推荐

  • MC病例定义为活检证实的显微镜性结肠炎。
  • 对照定义为因腹泻行结肠镜且活检排除MC的患者。
  • 匹配条件为年龄、性别和日历期,每例病例匹配最多两名对照。

临床怎么用

  • 对拟诊断显微镜性结肠炎的患者,应详细采集NSAID使用史。
  • PPI、H2受体阻滞剂和口服降糖药与MC的反向关联需谨慎解读,不宜据此直接改变用药。

局限性

  • 采用腹泻对照而非健康对照,可能促成PPI、H2受体阻滞剂和口服降糖药与MC的反向关联。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medication use has been implicated in the development of microscopic colitis (MC). However, studies have demonstrated inconsistent findings and there exist variations in design. AIM: To measure the association between medication use and MC. METHODS: Patients who underwent a colonoscopy over a 10-year period at two academic medical centres (Columbia University Medical Centre and Mayo Clinic) were identified. Cases were patients with biopsy-proven MC and controls were patients who underwent colonoscopy for evaluation of diarrhoea with biopsies negative for MC. Cases were matched by age, gender and calendar period with up to two controls. Demographics, medication use, smoking history and coeliac disease status were collected. Conditional logistic regression was used with and without adjustment for smoking. RESULTS: A total of 344 patients with MC were matched to 668 controls. After adjusting for smoking, there was an inverse association between MC and use of proton pump inhibitors (PPIs) (OR 0.64; 95% CI 0.47-0.87), H2 blockers (OR 0.46; 95% CI 0.24-0.88) and oral diabetes medications (OR 0.47; 95% CI 0.27-0.81). There was a positive association with nonsteroidal anti-inflammatory drug (NSAID) use and MC (OR 1.63; 95% CI 1.12-2.38). CONCLUSIONS: NSAID use was associated with MC, while use of PPIs, H2 blockers and oral diabetes medications were inversely related to MC. Our use of a control group with diarrhoea, as opposed to healthy controls, may have contributed to these inverse associations. Future studies of drug-induced microscopic colitis should include control groups with diarrhoea, and not only healthy controls.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Zylberberg HM, Kamboj AK, De Cuir N, et al. Medication use and microscopic colitis: a multicentre retrospective cohort study. Aliment Pharmacol Ther. 2021. PMID: 33852749. doi:10.1111/apt.16363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。